IRIS PubliCatt

Petito, Valentina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.090
NA - Nord America 1.906
AS - Asia 855
Continente sconosciuto - Info sul continente non disponibili 11
SA - Sud America 11
AF - Africa 6
OC - Oceania 2
Totale 4.881
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.877
IT - Italia 501
DE - Germania 483
CN - Cina 394
SE - Svezia 387
SG - Singapore 232
PL - Polonia 160
FR - Francia 127
IE - Irlanda 102
UA - Ucraina 101
ID - Indonesia 76
GB - Regno Unito 70
RU - Federazione Russa 46
IN - India 45
TR - Turchia 40
FI - Finlandia 35
BE - Belgio 26
CA - Canada 23
IR - Iran 15
NL - Olanda 14
HK - Hong Kong 13
KR - Corea 13
EU - Europa 11
ES - Italia 10
JP - Giappone 10
BR - Brasile 8
CZ - Repubblica Ceca 6
MX - Messico 5
AT - Austria 4
CI - Costa d'Avorio 4
CH - Svizzera 3
HU - Ungheria 3
KH - Cambogia 3
LT - Lituania 3
RO - Romania 3
VN - Vietnam 3
IL - Israele 2
KW - Kuwait 2
PT - Portogallo 2
TH - Thailandia 2
AL - Albania 1
AU - Australia 1
BD - Bangladesh 1
CL - Cile 1
CO - Colombia 1
EC - Ecuador 1
GL - Groenlandia 1
GR - Grecia 1
IQ - Iraq 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
RS - Serbia 1
SA - Arabia Saudita 1
TN - Tunisia 1
TW - Taiwan 1
UG - Uganda 1
Totale 4.881
Salva come PNG Salva come JPEG
Città #
Chandler 463
Singapore 187
Ashburn 154
Warsaw 142
Cattolica 107
Dublin 102
Beijing 91
Rome 83
Jacksonville 81
Ann Arbor 77
Jakarta 76
New York 62
San Mateo 55
Wilmington 50
Boston 45
Nanjing 44
Hangzhou 39
Izmir 38
Woodbridge 38
Milan 37
Princeton 36
Marseille 35
Moscow 35
Dearborn 34
Fairfield 31
Redwood City 27
Houston 26
Boardman 25
Nürnberg 25
Shanghai 25
Munich 24
Seattle 24
Lawrence 23
Los Angeles 22
Brussels 21
London 20
Kraków 17
Lancaster 17
Nanchang 17
Shenyang 17
Redmond 16
Bremen 15
Mountain View 14
Guangzhou 13
Zhengzhou 13
Tianjin 12
Cambridge 11
Fremont 11
Helsinki 11
Kish 11
Norwalk 11
Augusta 10
Hebei 10
Paris 10
Pune 10
Chicago 9
Jiaxing 9
Kunming 9
Leawood 8
Monza 8
Toronto 8
Washington 8
Andover 7
Seoul 7
Hong Kong 6
San Diego 6
Verona 6
Changsha 5
Frankfurt am Main 5
Hounslow 5
Jinan 5
Trieste 5
Abidjan 4
Catania 4
Changchun 4
Lanzhou 4
Mexico City 4
Montecorvino Rovella 4
Naples 4
Santa Clara 4
Tokyo 4
Vienna 4
Amsterdam 3
Baronissi 3
Brno 3
Budapest 3
Busto Arsizio 3
Clearwater 3
Falls Church 3
Fiano Romano 3
Grazzanise 3
Hefei 3
Kharkov 3
Lecco 3
Monmouth Junction 3
São Paulo 3
Trento 3
Unirea 3
Wageningen 3
Aachen 2
Totale 2.859
Salva come PNG Salva come JPEG
Nome #
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 295
Gut Microbiota Modulation and Mucosal Immunity: Focus on Rifaximin 160
Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a 'patchy cutaneous' immune suppression? 153
Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol-associated liver disease 149
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis 135
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders? 131
13C-octanoic acid breath test to study gastric emptying time 129
Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for 'gut barrier protectors' in IBD? 129
Role and mechanisms of action of Escherichia coli nissle 1917 in the maintenance of remission in ulcerative colitis patients: an update 124
Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide 117
Skeletal muscle-gut axis: Emerging mechanisms of sarcopenia for intestinal and extra intestinal diseases 112
The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors 110
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin 104
Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice 103
Intestinal gas production and gastrointestinal symptoms: from pathogenesis to clinical implication 97
Tricks for interpreting and making a good report on hydrogen and 13C breath tests 94
Gut microbial flora, prebiotics and probiotics in IBD: their current usage and utility 92
Dysbiosis, gut microbiota modulation and intestinal permeability in recurrent cystitis patients and concomitant gastrointestinal pathologies 89
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives 88
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives 88
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 86
Commensal Clostridia: leading players in the maintenance of gut homeostasis 85
Akkermansia muciniphila: key player in metabolic and gastrointestinal disorders 83
Specific 13C functional pathways as diagnostic targets in gastroenterology breath-tests: tricks for a correct interpretation 81
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab 77
Hepatocellular Carcinoma is Associated with Gut Microbiota Profile and Inflammation in Non-Alcoholic Fatty Liver Disease 73
Direct effect of infliximab on intestinal mucosa sustains mucosal healing: Exploring new mechanisms of action 73
Clinical, histopathological, and immunological evaluation of a series of patients with erythema nodosum 72
Gut microbiota and inflammatory bowel disease: an update 72
Characterization of Sarcopenia in an IBD Population Attending an Italian Gastroenterology Tertiary Center 71
Secretome modulation of Caco-2 cell line induced by a multi-strain probiotic 71
Characterization of the gut-liver-muscle axis in cirrhotic patients with sarcopenia 69
Gut Microbiota: A Key Modulator of Intestinal Healing in Inflammatory Bowel Disease 67
Dietary Magnesium Alleviates Experimental Murine Colitis Through Upregulation of the Transient Receptor Potential Melastatin 6 Channel 66
Liver Injury, Endotoxemia, and Their Relationship to Intestinal Microbiota Composition in Alcohol-Preferring Rats 64
Intestinal permeability in physiological and pathological conditions: major determinants and assessment modalities 60
Tumor necrosis factor-α and solute carrier family 22 member 4 gene polymorphisms as potential determinants of intestinal dysbiosis 60
Combination therapy in inflammatory bowel disease – from traditional immunosuppressors towards the new paradigm of dual targeted therapy 59
SECRETOME MODULATION OF CACO2 CELL LINE INDUCED BY A MULTI-STRAIN PROBIOTIC 53
Infliximab does not increase colonic cancer risk associated to murine chronic colitis 53
Dietary magnesium alleviates experimental murine colitis through modulation of gut microbiota 51
Anti-TNF-α-induced psoriasiform lesions in IBD: An abnormal immune activation or a 'patchy cutaneous' immune suppression? 50
Combination therapy in inflammatory bowel disease – from traditional immunosuppressors towards the new paradigm of dual targeted therapy 49
Evaluation of tolerability and major factors affecting the adherence to probiotic therapy in patients with irritable bowel syndrome: a prospective, observational, real-life study 47
The gut–brain axis in irritable bowel syndrome and inflammatory bowel disease 47
Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study 43
Gut Dysbiosis and Fecal Calprotectin Predict Response to Immune Checkpoint Inhibitors in Patients With Hepatocellular Carcinoma 42
Gut–joint axis: The role of physical exercise on gut microbiota modulation in older people with osteoarthritis 42
Increased Faecalibacterium abundance is associated with clinical improvement in patients receiving rifaximin treatment 41
Impact of the Trophic Effects of the Secretome from a Multistrain Probiotic Preparation on the Intestinal Epithelia 41
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease 40
Inflammatory Bowel Diseases and Sarcopenia: The Role of Inflammation and Gut Microbiota in the Development of Muscle Failure 40
Gut Microbiota Signatures Are Associated With Psychopathological Profiles in Patients With Ulcerative Colitis: Results From an Italian Tertiary IBD Center 36
Characterization of mucosal cytokine profile in ulcerative colitis patients under conventional and anti-TNF-a treatment 35
Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis 35
Effect of a multistrain probiotic on leaky gut in patients with diarrhea-predominant irritable bowel syndrome (IBS-D): a pilot study 34
Bariatric procedures and microbiota: patient selection and outcome prediction 34
The thrilling journey of sars-cov-2 into the intestine: From pathogenesis to future clinical implications 32
Towards a disease-associated common trait of gut microbiota dysbiosis: The pivotal role of Akkermansia muciniphila 31
Influence of hepatitis C virus eradication with direct-acting antivirals on the gut microbiota in patients with cirrhosis 29
Ecology and Machine Learning-Based Classification Models of Gut Microbiota and Inflammatory Markers May Evaluate the Effects of Probiotic Supplementation in Patients Recently Recovered from COVID-19 28
Bile Acid-Related Regulation of Mucosal Inflammation and Intestinal Motility: From Pathogenesis to Therapeutic Application in IBD and Microscopic Colitis 28
Adverse Food Reactions in Inflammatory Bowel Disease: State of the Art and Future Perspectives 26
MicroRNAs as Innovative Biomarkers for Inflammatory Bowel Disease and Prediction of Colorectal Cancer 26
IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair 22
[Microbiota and inflammatory bowel disease: an update.] 22
Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study 19
An Integrative Multi-omic Analysis defines Gut Microbiota, Mycobiota and Metabolic fingerprints in Ulcerative Colitis Patients 18
Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review 18
ToF-SIMS and principal component analysis of lipids and amino acids from inflamed and dysplastic human colonic mucosa 18
Cellular and Molecular Determinants of Biologic Drugs Resistance and Therapeutic Failure in Inflammatory Bowel Disease 17
Extrachromosomal Circular DNA: An Emerging Potential Biomarker for Inflammatory Bowel Diseases? 14
Functional hypothalamic amenorrhea: gut microbiota composition and the effects of exogenous estrogen administration 14
Direct effect of infliximab on intestinal mucosa sustains mucosal healing: Exploring new mechanisms of action 9
Circular and Circulating DNA in Inflammatory Bowel Disease: From Pathogenesis to Potential Molecular Therapies 9
Focus on Immune Checkpoint Inhibitors-related Intestinal Inflammation: From Pathogenesis to Therapeutical Approach 5
Totale 4.986
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.377
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.377
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020357 0 0 0 0 43 36 56 21 59 38 78 26
2020/2021390 30 35 7 35 48 25 35 10 43 20 81 21
2021/2022572 57 28 21 25 49 22 12 79 32 50 110 87
2022/20231.250 161 178 96 199 76 151 56 87 144 19 43 40
2023/2024780 46 176 29 43 32 101 49 27 43 34 85 115
2024/2025392 42 45 136 54 115 0 0 0 0 0 0 0
Totale 4.986